Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00663507 · ClinicalTrials.gov registry record
Kidney Transplantation in Patients With Sickle Cell Disease
A clinical trial, sponsored by Emory University.
- Terminated
- Registry status
- 2
- Enrollment target
NCT00663507: Clinical Trial study, sponsored by Emory University.
NCT00663507 is a clinical trial that was terminated before completion, run by Emory University. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00663507 was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this research is to better characterize the components and mechanisms of the immune systems of persons with sickle cell disease who have had a kidney transplant and are immunosuppressed. If we can improve our scientific understanding of the fundamental mechanisms involved in patient outcomes, we can potentially maximize the benefits that we seek from transplantation in sickle cell patients with end stage renal disease.
Primary Outcome
One 12 month participant, with no actions. One subject was a screen failure due to hepatitis C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2008-03 |
| Est. Completion | 2010-12 |
Why NCT00663507 stopped before completion
NCT00663507 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00663507 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00663507 about?
NCT00663507 is a clinical study titled "Kidney Transplantation in Patients With Sickle Cell Disease". The purpose of this research is to better characterize the components and mechanisms of the immune systems of persons with sickle cell disease who have had a kidney transplant and are immunosuppressed. If we can improve our scientific understanding of the fundamental mechanisms involved in patient o...
What is the current status of trial NCT00663507?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2008-03. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT00663507?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia